US Broker Ratings

NeoGenomics, Inc. (NEO) Stock Analysis: Navigating Growth with a 10.2% Revenue Surge in the Healthcare Sector

NeoGenomics, Inc. (NASDAQ: NEO) is making waves in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Fort Myers, Florida, NeoGenomics operates a..

Opko Health, Inc. (OPK) Investor Outlook: 136.93% Potential Upside Amidst Challenging Metrics

Opko Health, Inc. (NASDAQ: OPK), a healthcare company deeply entrenched in the diagnostics and pharmaceuticals sectors, presents a compelling, albeit complex, investment opportunity. With a market..

Wave Life Sciences Ltd. (WVE) Investor Outlook: A 153% Potential Upside Beckons

Wave Life Sciences Ltd. (NASDAQ: WVE) offers a compelling investment opportunity with a robust 153.52% potential upside, according to recent analyst ratings. The Singapore-based biotechnology company..

10x Genomics, Inc. (TXG) Stock Analysis: A 13.07% Potential Upside in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG) has been capturing the attention of investors who are keen on the healthcare sector, especially those with an interest in health..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Unlocking a 9.42% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a key player in the Medical Care Facilities industry, is attracting attention from investors with its significant potential upside of..

AdaptHealth Corp. (AHCO) Stock Analysis: Potential 37.28% Upside Amid Strong Buy Ratings

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector specializing in medical devices, is drawing attention from individual investors with its compelling growth potential...

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring an 80% Upside Potential in the Biotech Sector

MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology sector, presents a compelling investment opportunity for those looking to capitalize on the rapidly evolving..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 55% Potential Upside with Strong Buy Ratings

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a trailblazer in the biotechnology sector, is capturing investor interest with its precision medicine approach to oncology. The South San Francisco-based..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Strong Buy Ratings Propel 13% Potential Upside

BioLife Solutions, Inc. (NASDAQ: BLFS) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.33 billion,..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Unpacking a Potential 58% Upside Amidst Clinical Achievements

For investors with an eye on the biotechnology sector, Viridian Therapeutics, Inc. (NASDAQ: VRDN) presents a compelling opportunity with a potential upside of 58.26%, according to..

SS Innovations International (SSII) Stock Analysis: A Surgical Robotics Pioneer with Impressive Revenue Growth

SS Innovations International Inc. (NASDAQ: SSII) is making waves in the healthcare sector with its innovative approach to surgical robotics. Headquartered in Gurugram, India, the company..

Clover Health Investments Corp (CLOV): Investor Outlook Reveals 15.30% Potential Upside in Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) continues to capture the attention of investors within the healthcare sector. Specializing in Medicare Advantage plans, Clover Health offers innovative..

agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with a 24.59% Potential Upside

agilon health, inc. (NYSE: AGL) stands as a unique player in the healthcare sector, specifically within medical care facilities, focusing on providing healthcare services to seniors..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A 12% Potential Upside in the Healthcare Sector

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) has carved a niche for itself in the healthcare sector, specifically within the medical care facilities industry. As an Atlanta-based..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Exploring an 84.83% Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is gaining attention in the biotechnology sector with its focused mission to develop groundbreaking treatments for rare diseases. This Princeton, New..

Evolent Health, Inc (EVH) Stock Analysis: A 99% Potential Upside with Strong Buy Ratings

Evolent Health, Inc. (NYSE: EVH) stands out in the healthcare sector, specifically within the Health Information Services industry, as an intriguing investment opportunity. With a market..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A Biotech Innovator with 79.94% Potential Upside

Ocular Therapeutix, Inc. (OCUL), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach in developing therapies for retinal diseases and..

The Pennant Group, Inc. (PNTG) Stock Analysis: Unlocking a 40% Potential Upside in Healthcare

The Pennant Group, Inc. (NASDAQ: PNTG) is gaining attention among investors with its strong potential upside of 40% based on current analyst projections. Operating in the..

Kestra Medical Technologies (KMTS) Stock Report: Healthcare Innovator with a 51.5% Revenue Growth

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a prominent player in the healthcare sector, is capturing investor attention with its impressive revenue growth and innovative approach to..

Harrow, Inc. (HROW) Stock Analysis: Exploring a 61.82% Upside Potential in the Specialty Pharma Sector

In the vibrant landscape of the healthcare sector, Harrow, Inc. (NASDAQ: HROW) is capturing the attention of investors with its bold prospects. Specializing in ophthalmic pharmaceuticals,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds